| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5CSZ8459RP |
| InChI Key | UHDGCWIWMRVCDJ-XVFCMESISA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C9H13N3O5 |
| Molecular Weight | 243.22 |
| AlogP | -2.56 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 130.83 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 17.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 1 | |
|
Enzyme
|
- | - | - | - | 1 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 114 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Bipolar Disorder | 2 | D001714 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 17562 |
| ChEMBL | CHEMBL95606 |
| DrugBank | DB02097 |
| EPA CompTox | DTXSID60891552 |
| FDA SRS | 5CSZ8459RP |
| Guide to Pharmacology | 4728 |
| KEGG | C00475 |
| PDB | CTN |
| PubChem | 6175 |
| SureChEMBL | SCHEMBL7179 |
| ZINC | ZINC000002583632 |